• 1. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Monosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Monosaccharides

Recent Advances in the Study of b-L-Fucopyranosylamine (CAS: 103419-79-0) in Chemical Biology and Medicine

The compound b-L-Fucopyranosylamine (CAS: 103419-79-0) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of b-L-Fucopyranosylamine as a key intermediate in the synthesis of glycosidase inhibitors, which are of great interest for the treatment of diseases such as diabetes, viral infections, and cancer. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of b-L-Fucopyranosylamine exhibit potent inhibitory activity against α-L-fucosidase, an enzyme implicated in various pathological processes, including tumor metastasis and inflammation.

In addition to its enzymatic inhibitory properties, b-L-Fucopyranosylamine has been investigated for its potential as a glycomimetic. A recent paper in Angewandte Chemie International Edition (2024) described the use of this compound in the design of novel carbohydrate-based vaccines. The study showed that b-L-Fucopyranosylamine can be conjugated to carrier proteins to elicit a robust immune response, opening new avenues for vaccine development against bacterial and viral pathogens.

From a synthetic chemistry perspective, advances in the efficient production of b-L-Fucopyranosylamine have been reported. A 2024 study in Organic Letters detailed a novel enzymatic method for the stereoselective synthesis of this compound, achieving high yields and purity. This development is particularly significant for scaling up production for preclinical and clinical studies.

Looking forward, the unique properties of b-L-Fucopyranosylamine position it as a promising candidate for further exploration in drug discovery and development. Ongoing research is focusing on optimizing its pharmacokinetic properties and exploring its potential in targeted therapies. The compound's versatility and biological relevance make it a valuable tool for both basic research and applied medicinal chemistry.

• 7284-37-9((2R,3R,4S,5S,6R)-2-amino-6-(hydroxymethyl)oxane-3,4,5-triol)
• 6318-23-6(b-D-Galactopyranosylamine)
• 43179-09-5(D-Ribopyranosylamine)
• 74867-91-7((2R,3R,4S,5R,6R)-2-Amino-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)